Trevena Company Profile (NASDAQ:TRVN)

About Trevena

Trevena logoTrevena Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops and intends to commercialize therapeutics that use an approach to target G protein coupled receptors (GPCRs). Using its product platform, the Company has identified and advanced three differentiated product candidates: Oliceridine (TRV130), TRV027 and TRV250. Its TRV130 is a Mu-receptor G protein Pathway Selective (Mu-GPS) modulator that activates G protein. Its TRV250 is a small molecule G protein biased ligand of the d-opioid receptor in preclinical development. Its TRV734 is a small molecule Mu-GPS that it has discovered and has developed through Phase I as a first-line, orally administered compound for the treatment of moderate to severe acute and chronic pain. Its TRV027 is a peptide b-arrestin biased ligand that targets the angiotensin II type 1 receptor (AT1R). In addition to these three product candidates, the Company has identified and has completed the Phase I program for TRV734.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TRVN
  • CUSIP:
Key Metrics:
  • Previous Close: $7.04
  • 50 Day Moving Average: $6.83
  • 200 Day Moving Average: $7.48
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.60
  • P/E Growth: 0.00
  • Market Cap: $367.33M
  • Outstanding Shares: 52,178,000
  • Beta: -0.62
Additional Links:
Companies Related to Trevena:

Analyst Ratings

Consensus Ratings for Trevena (NASDAQ:TRVN) (?)
Ratings Breakdown: 10 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.78 (109.91% upside)

Analysts' Ratings History for Trevena (NASDAQ:TRVN)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016Cowen and CompanyReiterated RatingBuy$13.00View Rating Details
8/5/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/5/2016Brean CapitalReiterated RatingBuy$14.00View Rating Details
8/4/2016FBR & CoReiterated RatingBuy$13.00View Rating Details
5/17/2016WedbushReiterated RatingOutperform$20.00 -> $16.00View Rating Details
5/17/2016Needham & Company LLCReiterated RatingBuy$14.00 -> $11.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$21.00 -> $18.00View Rating Details
3/2/2016WallachBeth CapitalInitiated CoverageBuy$18.00View Rating Details
2/24/2016Barclays PLCLower Price TargetOverweight$18.00 -> $15.00View Rating Details
9/2/2015Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Trevena (NASDAQ:TRVN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/4/2016($0.36)($0.37)ViewN/AView Earnings Details
5/5/2016Q1($0.32)($0.35)ViewN/AView Earnings Details
3/9/2016Q415($0.26)($0.30)$1.64 million$1.88 millionViewListenView Earnings Details
11/10/2015Q3($0.34)($0.24)ViewN/AView Earnings Details
8/11/2015Q215($0.37)($0.28)$1.88 millionViewN/AView Earnings Details
5/7/2015($0.33)($0.33)ViewN/AView Earnings Details
3/18/2015Q414($0.39)($0.45)ViewN/AView Earnings Details
11/11/2014Q314($0.45)($0.59)ViewN/AView Earnings Details
8/12/2014($0.35)($0.44)ViewN/AView Earnings Details
5/9/2014Q114($0.36)($0.59)$0.03 million$0.04 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Trevena (NASDAQ:TRVN)
Current Year EPS Consensus Estimate: $-1.55 EPS
Next Year EPS Consensus Estimate: $-1.53 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165($0.33)($0.24)($0.29)
Q2 20165($0.38)($0.27)($0.33)
Q3 20164($0.43)($0.24)($0.35)
Q4 20165($0.45)($0.26)($0.34)
Q1 20171($0.45)($0.45)($0.45)
Q2 20171($0.44)($0.44)($0.44)
Q3 20171($0.40)($0.40)($0.40)
Q4 20171($0.45)($0.45)($0.45)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Trevena (NASDAQ:TRVN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Trevena (NASDAQ:TRVN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/27/2016Maxine GowenCEOBuy22,084$7.12$157,238.08View SEC Filing  
12/10/2015David SoergelCMOSell27,217$10.55$287,139.35View SEC Filing  
12/12/2014John M LimongelliVPBuy3,000$4.14$12,420.00View SEC Filing  
12/10/2014Enterprise Associates 12 NewMajor ShareholderBuy1,000,000$4.00$4,000,000.00View SEC Filing  
12/10/2014Maxine GowenCEOBuy8,000$4.00$32,000.00View SEC Filing  
12/10/2014Michael R DoughertyDirectorBuy7,000$4.00$28,000.00View SEC Filing  
12/10/2014Michael W LarkVPBuy5,000$4.00$20,000.00View SEC Filing  
12/10/2014Roberto CucaCFOBuy25,000$4.00$100,000.00View SEC Filing  
12/9/2014Leon O Moulder JrDirectorBuy30,200$3.96$119,592.00View SEC Filing  
9/29/2014Rosamond DeeganSVPSell44$7.00$308.00View SEC Filing  
2/5/2014Laboratories Holdings L ForestMajor ShareholderBuy428,571$7.00$2,999,997.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Trevena (NASDAQ:TRVN)
DateHeadline
capitalcube.com logoETF’s with exposure to Trevena, Inc. : August 16, 2016 (NASDAQ:TRVN)
www.capitalcube.com - August 16 at 7:58 PM
capitalcube.com logoTrevena, Inc. :TRVN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:TRVN)
www.capitalcube.com - August 12 at 8:03 PM
finance.yahoo.com logoTREVENA INC Financials (NASDAQ:TRVN)
finance.yahoo.com - August 11 at 8:31 PM
News IconTrevena to Present at the 2016 Wedbush Pacgrow Healthcare Conference (NASDAQ:TRVN)
www.cbs58.com - August 10 at 11:04 AM
capitalcube.com logoETF’s with exposure to Trevena, Inc. : August 5, 2016 (NASDAQ:TRVN)
www.capitalcube.com - August 5 at 8:07 PM
finance.yahoo.com logoCompany Profile for Trevena, Inc. (NASDAQ:TRVN)
finance.yahoo.com - August 5 at 10:58 AM
News IconTrevena Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:TRVN)
www.enhancedonlinenews.com - August 4 at 11:09 AM
rttnews.com logoEARNINGS SUMMARY: Details of Trevena, Inc. Q2 Earnings Report (NASDAQ:TRVN)
www.rttnews.com - August 4 at 11:09 AM
sg.finance.yahoo.com logoTrevena reports 2Q loss (NASDAQ:TRVN)
sg.finance.yahoo.com - August 4 at 11:09 AM
publicnow.com logo8/4/16 - Trevena Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:TRVN)
www.publicnow.com - August 4 at 11:09 AM
News IconEquity Roundup: Stock Performance Focus on Trevena, Inc. (NASDAQ:TRVN) - Press Telegraph (NASDAQ:TRVN)
presstelegraph.com - July 23 at 11:40 AM
News IconDoes Trevena Inc Have Any Gas After Today's Huge Increase? - Consumer Eagle (NASDAQ:TRVN)
www.consumereagle.com - July 22 at 10:50 AM
News IconTrevena, Inc. (NASDAQ:TRVN): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:TRVN)
www.engelwooddaily.com - July 20 at 8:57 PM
News IconHow Analysts Feel About Trevena Inc (NASDAQ:TRVN)? - Consumer Eagle (NASDAQ:TRVN)
www.consumereagle.com - July 19 at 8:53 AM
News IconShares Experiencing a Downtrend: Trevena, Inc. (NASDAQ:TRVN) - TGP (NASDAQ:TRVN)
telanaganapress.com - July 16 at 11:03 AM
fiscalstandard.com logoBroker Outlook For Trevena Inc (NASDAQ:TRVN) - Fiscal Standard (NASDAQ:TRVN)
www.fiscalstandard.com - July 16 at 11:03 AM
news.cmlviz.com logoTrevena Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:TRVN)
news.cmlviz.com - July 15 at 1:12 PM
News IconTrevena Inc Stock Price Declines Today - Consumer Eagle (NASDAQ:TRVN)
www.consumereagle.com - July 14 at 8:09 PM
News IconEye on Stock Volatility for: Trevena, Inc. (NASDAQ:TRVN) - Engelwood Daily (NASDAQ:TRVN)
www.engelwooddaily.com - July 14 at 8:09 PM
News IconInsiders Increasing Positions in: Trevena, Inc. (NASDAQ:TRVN) - Press Telegraph (NASDAQ:TRVN)
presstelegraph.com - July 14 at 8:09 PM
News IconWall Street Ratings and Target Price Views on Trevena, Inc. (NASDAQ:TRVN) - Telanagana Press (NASDAQ:TRVN)
telanaganapress.com - July 11 at 7:48 PM
News IconHow Many Trevena Inc (NASDAQ:TRVN)'s Analysts Are Bearish? - Engelwood Daily (NASDAQ:TRVN)
www.engelwooddaily.com - July 11 at 7:48 PM
News IconStock Tracking Down This Month; Investor Alert on Trevena, Inc. (NASDAQ:TRVN) - Engelwood Daily (NASDAQ:TRVN)
www.engelwooddaily.com - July 6 at 8:22 PM
investornewswire.com logoWill Trevena, Inc. (NASDAQ:TRVN) Surprise Analysts? - Investor Newswire (NASDAQ:TRVN)
www.investornewswire.com - July 6 at 8:22 PM
News IconHow Analysts Feel About Trevena Inc (NASDAQ:TRVN)? - Press Telegraph (NASDAQ:TRVN)
presstelegraph.com - July 5 at 8:52 AM
fiscalstandard.com logoTrevena Inc (NASDAQ:TRVN) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:TRVN)
www.fiscalstandard.com - July 5 at 8:47 AM
fool.com logoThese 3 Biotech Stocks Are Ridiculously Cheap Now (NASDAQ:TRVN)
www.fool.com - July 5 at 8:22 AM
News IconCovering the Bases on Trevena, Inc. (NASDAQ:TRVN): Where is the Stock Going? - Press Telegraph (NASDAQ:TRVN)
presstelegraph.com - June 28 at 7:49 PM
fool.com logo3 Growth Stocks to Buy in July (NASDAQ:TRVN)
www.fool.com - June 28 at 11:07 AM
kcregister.com logoTrevena, Inc. (NASDAQ:TRVN) Surged 8.86% Afterhours: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ... - KC Register (NASDAQ:TRVN)
www.kcregister.com - June 24 at 10:28 AM
news.cmlviz.com logoTrevena, Inc. (NASDAQ:TRVN) Stock Momentum Hits EXTREME Weakness - CML News (NASDAQ:TRVN)
news.cmlviz.com - June 23 at 8:40 PM
bizjournals.com logoBiotechnology Stocks in Motion -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera Pharma (NASDAQ:TRVN)
www.bizjournals.com - June 22 at 9:00 AM
4-traders.com logoAnthera Pharmaceuticals : Biotechnology Stocks in Motion -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera Pharma (NASDAQ:TRVN)
www.4-traders.com - June 22 at 9:00 AM
investors.com logoAllergan Carves Middle Path In R&D Spending With 'Open Science' (NASDAQ:TRVN)
www.investors.com - June 17 at 7:00 AM
publicnow.com logo6/16/16 - Trevena to Present at the JMP Life Sciences Conference (NASDAQ:TRVN)
www.publicnow.com - June 16 at 4:49 PM
finance.yahoo.com logoTrevena to Present at the JMP Life Sciences Conference (NASDAQ:TRVN)
finance.yahoo.com - June 16 at 4:01 PM
marketexclusive.com logoTrevena Inc (NASDAQ:TRVN) Just Got Its Billion Dollar Pain Management Bid Underway - Market Exclusive (NASDAQ:TRVN)
marketexclusive.com - June 9 at 8:27 PM
insidermonkey.com logoTrevena Inc (TRVN) Just Got Its Billion Dollar Pain Management Bid Underway - Insider Monkey (blog) (NASDAQ:TRVN)
www.insidermonkey.com - June 9 at 11:00 AM
News IconTrevena Inc (TRVN) Just Got Its Billion Dollar Pain Management Bid Underway (NASDAQ:TRVN)
feedproxy.google.com - June 9 at 10:34 AM
bizjournals.com logoKing of Prussia firm begins late-stage testing of new type of pain medicine (NASDAQ:TRVN)
www.bizjournals.com - June 8 at 12:15 PM
businesswire.com logoTrevena, Inc. Announces First Patients Enrolled in the APOLLO-1 and APOLLO-2 Phase 3 Pivotal Efficacy Studies of ... - Business Wire (press release) (NASDAQ:TRVN)
www.businesswire.com - June 8 at 11:02 AM
publicnow.com logo6/8/16 - Trevena, Inc. Announces First Patients Enrolled in the APOLLO-1 and APOLLO-2 Phase 3 Pivotal Efficacy Studies of Oliceridine in Acute Pain (NASDAQ:TRVN)
www.publicnow.com - June 8 at 9:18 AM
finance.yahoo.com logoTrevena, Inc. Announces First Patients Enrolled in the APOLLO-1 and APOLLO-2 Phase 3 Pivotal Efficacy Studies of Oliceridine in Acute Pain (NASDAQ:TRVN)
finance.yahoo.com - June 8 at 7:00 AM
isstories.com logoPortfolio Of Healthcare Movers: Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) , Trevena, Inc. (NASDAQ:TRVN) - Is stories (NASDAQ:TRVN)
www.isstories.com - June 5 at 10:36 AM
News IconCowen and Company Reiterates Buy Rating for Trevena Inc (TRVN) - Let Me Know About This (NASDAQ:TRVN)
www.lmkat.com - June 3 at 8:38 PM
capitalcube.com logoTrevena, Inc. breached its 50 day moving average in a Bullish Manner : TRVN-US : June 2, 2016 (NASDAQ:TRVN)
www.capitalcube.com - June 2 at 8:10 AM
finance.yahoo.com logoTrevena to Present at the Jefferies 2016 Healthcare Conference (NASDAQ:TRVN)
finance.yahoo.com - June 1 at 4:01 PM
News IconTrevena Inc (TRVN) Receives Buy Rating from FBR & Co. - Let Me Know About This (NASDAQ:TRVN)
www.lmkat.com - June 1 at 10:54 AM
News IconShare Rating Focus on Trevena, Inc. (NASDAQ:TRVN) - HNN (NASDAQ:TRVN)
hintsnewsnetwork.com - May 31 at 8:19 PM
News IconMaxine Gowen the President & CEO of Trevena Inc (NASDAQ:TRVN), Made a Purchase of 22084 Shares of the ... - HNN (NASDAQ:TRVN)
hintsnewsnetwork.com - May 31 at 8:19 PM

Social

Trevena (NASDAQ:TRVN) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff